| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/82_2014_390 |
| P8608 | Fatcat ID | release_t2j2gjwta5hanloaywnbkr6wiu |
| P932 | PMC publication ID | 7121145 |
| P698 | PubMed publication ID | 25001209 |
| P5875 | ResearchGate publication ID | 263740253 |
| P50 | author | Nicole M. Bouvier | Q54081113 |
| P2093 | author name string | Anice C Lowen | |
| John Steel | |||
| P2860 | cites work | Influenza virus transmission is dependent on relative humidity and temperature | Q21090528 |
| Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals | Q22255464 | ||
| Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus | Q23921202 | ||
| Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model | Q24670511 | ||
| Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic | Q27675496 | ||
| Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
| H5N1 Virus Attachment to Lower Respiratory Tract | Q28303460 | ||
| Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. | Q28369317 | ||
| Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in ferrets | Q28386553 | ||
| Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase | Q28387364 | ||
| The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs | Q28387864 | ||
| Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus | Q28388794 | ||
| Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo | Q28391618 | ||
| Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses | Q28476212 | ||
| Oseltamivir resistance during treatment of influenza A (H5N1) infection | Q29618722 | ||
| Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic | Q29619055 | ||
| Avian flu: influenza virus receptors in the human airway | Q29619374 | ||
| Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries | Q30223476 | ||
| Influenza virus aerosol exposure and analytical system for ferrets | Q30226595 | ||
| Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir | Q30306773 | ||
| Characterization of H7N9 influenza A viruses isolated from humans. | Q30352001 | ||
| The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. | Q30352150 | ||
| H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. | Q30352214 | ||
| Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. | Q30353256 | ||
| Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans | Q30353549 | ||
| Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. | Q30354091 | ||
| The guinea pig as a transmission model for human influenza viruses | Q30355013 | ||
| Animal models in influenza vaccine testing. | Q30371058 | ||
| Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. | Q30371242 | ||
| Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. | Q30374182 | ||
| Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding | Q30374356 | ||
| Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets | Q30374748 | ||
| Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. | Q30374897 | ||
| Transmission of influenza virus via aerosols and fomites in the guinea pig model. | Q30376991 | ||
| Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. | Q30381638 | ||
| Adaptive strategies of the influenza virus polymerase for replication in humans | Q30383307 | ||
| Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host | Q30383968 | ||
| Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice | Q39127763 | ||
| H5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory droplet | Q39156660 | ||
| Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors | Q39577999 | ||
| Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir | Q40202446 | ||
| Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. | Q40246690 | ||
| The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. | Q40579225 | ||
| Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets | Q40580607 | ||
| In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir | Q40911739 | ||
| Influenza virus infection of the guinea pig: Immune response and resistance | Q41513828 | ||
| Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs | Q41814537 | ||
| Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus. | Q43175226 | ||
| Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo | Q44025966 | ||
| Resistant influenza A viruses in children treated with oseltamivir: descriptive study | Q45036693 | ||
| Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets | Q45101875 | ||
| Lung alterations in guinea-pigs infected with influenza virus | Q45796359 | ||
| Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids | Q45885838 | ||
| Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs | Q46918578 | ||
| Induction of systemic delayed hypersensitivity during experimental viral infection of the respiratory tract with a myxovirus or paramyxovirus. | Q53985392 | ||
| A recombinant human interferon-alpha B/D hybrid with a broad host-range | Q70166751 | ||
| Human Influenza Resulting from Aerosol Inhalation | Q72799774 | ||
| Experimental transmission in guinea pigs of H9N2 avian influenza viruses from indoor air of chicken houses | Q87395817 | ||
| Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. | Q30385814 | ||
| Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. | Q30392964 | ||
| Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding | Q30393671 | ||
| Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain | Q30396352 | ||
| Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic | Q30396905 | ||
| The global spread of drug-resistant influenza | Q30406360 | ||
| The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model | Q30406570 | ||
| Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model | Q30424185 | ||
| Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses | Q30425354 | ||
| Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution | Q30430014 | ||
| Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. | Q30431009 | ||
| Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus | Q30472691 | ||
| Clinical findings in 111 cases of influenza A (H7N9) virus infection | Q33407904 | ||
| Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host | Q33614393 | ||
| Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals | Q33987458 | ||
| Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility | Q34077100 | ||
| Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses | Q34102756 | ||
| Time lines of infection and disease in human influenza: a review of volunteer challenge studies | Q34743132 | ||
| Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en | Q35857200 | ||
| Transmission of influenza B viruses in the guinea pig. | Q35868018 | ||
| Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. | Q35882160 | ||
| Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque | Q36023157 | ||
| Influenza virus infection in guinea pigs raised as livestock, Ecuador | Q36037784 | ||
| Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses | Q36316118 | ||
| Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures | Q36607072 | ||
| A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. | Q36685680 | ||
| Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host | Q36760138 | ||
| Blocking interhost transmission of influenza virus by vaccination in the guinea pig model | Q37127910 | ||
| Limited airborne transmission of H7N9 influenza A virus between ferrets | Q37284438 | ||
| Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. | Q37394266 | ||
| Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model | Q37547355 | ||
| Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models | Q37713928 | ||
| High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus | Q38610252 | ||
| Avian influenza--a challenge to global health care structures | Q39067037 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 157-183 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Transmission in the guinea pig model. | |
| P478 | volume | 385 |
| Q35998278 | Animal models for influenza virus transmission studies: a historical perspective. |
| Q93241084 | Animal models for the risk assessment of viral pandemic potential |
| Q40041986 | Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus |
| Q92639104 | Dysregulation of M segment gene expression contributes to influenza A virus host restriction |
| Q89511393 | Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine |
| Q41933705 | Influenza A Virus Studies in a Mouse Model of Infection. |
| Q54230830 | Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk. |
| Q40901270 | Influenza virus emitted by naturally-infected hosts in a healthcare setting. |
| Q64273864 | Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs |
| Q38834806 | Replication and Transmission of the Novel Bovine Influenza D Virus in a Guinea Pig Model |
| Q35635820 | Swine as a model for influenza A virus infection and immunity |
| Q57093843 | The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses |
| Q27000668 | Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness |
Search more.